{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T07:25:39Z","timestamp":1767597939467,"version":"build-2065373602"},"reference-count":65,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2022,6,5]],"date-time":"2022-06-05T00:00:00Z","timestamp":1654387200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003243","name":"Ministry of Health of the Czech Republic","doi-asserted-by":"publisher","award":["NV19-02-00086"],"award-info":[{"award-number":["NV19-02-00086"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Cardiogenic shock is a state of reduced cardiac output leading to hypotension, pulmonary congestion, and hypoperfusion of tissues and vital organs. Despite the advances in intensive care over the last years, the morbidity and mortality of patients remain high. The available studies of patients with cardiogenic shock suggest a connection between clinical variables, the level of biomarkers, the results of imaging investigations, strategies of management and the outcome of this group of patients. The management of patients with cardiogenic shock initially complicating acute myocardial infarction is challenging, and the number of studies in this area is growing fast. The purpose of this review is to summarize the currently available evidence on cardiogenic shock initially complicating acute myocardial infarction with particular attention to predictors of prognosis, focusing on laboratory variables (established and new), and to discuss the practical implementation. Currently available scoring systems developed during the past few decades predict the clinical outcome of this group of patients using some of the established biomarkers among other variables. With the new laboratory biomarkers that have shown their predictive value in cardiogenic shock outcomes, a new design of scoring systems would be of interest. Identifying high-risk patients offers the opportunity for early decision-making.<\/jats:p>","DOI":"10.3390\/biomedicines10061328","type":"journal-article","created":{"date-parts":[[2022,6,5]],"date-time":"2022-06-05T10:47:11Z","timestamp":1654426031000},"page":"1328","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Laboratory Predictors of Prognosis in Cardiogenic Shock Complicating Acute Myocardial Infarction"],"prefix":"10.3390","volume":"10","author":[{"given":"Tamilla","family":"Muzafarova","sequence":"first","affiliation":[{"name":"Cardiocenter, Third Faculty of Medicine Charles University and University Hospital Kralovske Vinohrady, 10034 Prague, Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5319-473X","authenticated-orcid":false,"given":"Zuzana","family":"Motovska","sequence":"additional","affiliation":[{"name":"Cardiocenter, Third Faculty of Medicine Charles University and University Hospital Kralovske Vinohrady, 10034 Prague, Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,6,5]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/ejhf.260","article-title":"Clinical picture and risk prediction of short-term mortality in cardiogenic shock: clinical picture and outcome of cardiogenic shock","volume":"17","author":"Harjola","year":"2015","journal-title":"Eur. J. Heart Fail."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Hashmi, K.A., Abbas, K., Hashmi, A.A., Irfan, M., Edhi, M.M., Ali, N., and Khan, A. (2018). In-hospital mortality of patients with cardiogenic shock after acute myocardial infarction; impact of early revascularization. BMC Res. Notes, 11.","DOI":"10.1186\/s13104-018-3830-7"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1056\/NEJM199908263410901","article-title":"Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK investigators. Should we emergently revascularize occluded coronaries for cardiogenic shock","volume":"341","author":"Hochman","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1056\/NEJMoa1208410","article-title":"Intraaortic balloon support for myocardial infarction with cardiogenic shock","volume":"367","author":"Thiele","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.jchf.2020.09.005","article-title":"A Standardized and Comprehensive Approach to the Management of Cardiogenic Shock","volume":"8","author":"Tehrani","year":"2020","journal-title":"JACC. Heart Fail."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/ccd.28329","article-title":"SCAI clinical expert consensus statement on the classification of cardiogenic shock","volume":"94","author":"Baran","year":"2019","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ijcard.2015.04.242","article-title":"Prognostic impact of established and novel renal function biomarkers in myocardial infarction with cardiogenic shock: A biomarker substudy of the IABP-SHOCK II-trial","volume":"191","author":"Fuernau","year":"2015","journal-title":"Int. J. Cardiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.ahj.2009.08.005","article-title":"TRIUMPH Investigators. Predictors of 30-day mortality in patients with refractory cardiogenic shock following acute myocardial infarction despite a patent infarct artery","volume":"158","author":"Katz","year":"2009","journal-title":"Am. Heart J."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.amjcard.2005.02.040","article-title":"Mortality after emergent percutaneous coronary intervention in cardiogenic shock secondary to acute myocardial infarction and usefulness of a mortality prediction model","volume":"96","author":"Klein","year":"2005","journal-title":"Am. J. Cardiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ahj.2012.07.008","article-title":"Deadly association of cardiogenic shock and chronic total occlusion in acute ST-elevation myocardial infarction","volume":"164","author":"Bataille","year":"2012","journal-title":"Am. Heart J."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.ahj.2010.06.024","article-title":"A severity scoring system for risk assessment of patients with cardiogenic shock: a report from the SHOCK Trial and Registry","volume":"160","author":"Sleeper","year":"2010","journal-title":"Am. Heart J."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1016\/j.jacc.2017.02.027","article-title":"Risk stratification for patients in cardiogenic shock after acute myocardial infarction","volume":"69","author":"Fuernau","year":"2017","journal-title":"J. Am. Coll Cardiol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0002-8703(99)70241-3","article-title":"Cardiogenic shock complicating acute myocardial infarction: predictors of death. GUSTO Investigators. Global Utilization of Streptokinase and Tissue-Plasminogen Activator for Occluded Coronary Arteries","volume":"138","author":"Hasdai","year":"1999","journal-title":"Am. Heart J."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1177\/2048872615568966","article-title":"A simple risk chart for initial risk assessment of 30-day mortality in patients with cardiogenic shock from ST-elevation myocardial infarction","volume":"5","author":"Cheng","year":"2016","journal-title":"Eur. Heart J. Acute Cardiovasc. Care"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.amjcard.2008.12.033","article-title":"Early risk stratification of patients with cardiogenic shock complicating acute myocardial infarction who undergo percutaneous coronary intervention","volume":"103","author":"Arzamendi","year":"2009","journal-title":"Am. J. Cardiol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1093\/eurheartj\/ehab110","article-title":"The novel cystatin C, lactate, interleukin-6, and N-terminal pro-B-type natriuretic peptide (CLIP)-based mortality risk score in cardiogenic shock after acute myocardial infarction","volume":"42","author":"Ceglarek","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s10741-020-10034-0","article-title":"Cardiogenic shock and acute kidney injury: The rule rather than the exception","volume":"26","author":"Ghionzoli","year":"2020","journal-title":"Heart Fail. Rev."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/ejhf.958","article-title":"Acute kidney injury in cardiogenic shock: Definitions, incidence, haemodynamic alterations, and mortality","volume":"20","author":"Haapio","year":"2018","journal-title":"Eur. J. Heart Fail."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/CCM.0b013e3181b9eb3b","article-title":"Acute kidney injury in ST-segment elevation acute myocardial infarction complicated by cardiogenic shock at admission","volume":"38","author":"Marenzi","year":"2010","journal-title":"Crit. Care Med."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Singh, S., Kanwar, A., Sundaragiri, P., Cheungpasitporn, W., Truesdell, A., Rab, S., Singh, M., and Vallabhajosyula, S. (2021). Acute Kidney Injury in Cardiogenic Shock: An Updated Narrative Review. J. Cardiovasc. Dev. Dis., 28.","DOI":"10.3390\/jcdd8080088"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1097\/ALN.0b013e31824f951b","article-title":"Acute kidney injury and extrarenal organ dysfunction: new concepts and experimental evidence","volume":"116","author":"Yap","year":"2012","journal-title":"Anesthesiology"},{"key":"ref_23","first-page":"695","article-title":"Predictors of short term mortality in patients with acute ST-elevation myocardial infarction complicated by cardiogenic shock","volume":"38","author":"Liu","year":"2010","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"key":"ref_24","first-page":"743","article-title":"Blood glucose level on admission determines in-hospital and long-term mortality in patients with ST-segment elevation myocardial infarction complicated by cardiogenic shock treated with percutaneous coronary intervention","volume":"68","author":"Pres","year":"2010","journal-title":"Kardiol. Pol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.ahj.2007.07.028","article-title":"In patients with ST-segment elevation myocardial infarction with cardiogenic shock treated with percutaneous coronary intervention, admission glucose level is a strong independent predictor for 1-year mortality in patients without a prior diagnosis of diabetes","volume":"154","author":"Vis","year":"2007","journal-title":"Am. Heart J."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0167-5273(89)90078-8","article-title":"Electrocardiographic correlates of hyperglycaemia in acute myocardial infarction","volume":"22","author":"Gokhroo","year":"1989","journal-title":"Int. J. Cardiol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s001250051345","article-title":"The effect of acute hyperglycaemia on QTc duration in healthy man","volume":"43","author":"Marfella","year":"2000","journal-title":"Diabetologia"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0735-1097(02)02626-8","article-title":"Association between hyperglycaemia and the no-reflow phenomenon in patients with acute myocardial infarction","volume":"41","author":"Iwakura","year":"2003","journal-title":"J. Am. Coll Cardiol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0735-1097(95)00126-K","article-title":"Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year","volume":"26","author":"Malmberg","year":"1995","journal-title":"J. Am. Coll Cardiol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1136\/bmj.314.7093.1512","article-title":"Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group","volume":"314","author":"Malmberg","year":"1997","journal-title":"BMJ"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1016\/j.jcin.2020.06.037","article-title":"Arterial Lactate in Cardiogenic Shock: Prognostic Value of Clearance Versus Single Values","volume":"13","author":"Fuernau","year":"2020","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/SHK.0000000000001191","article-title":"Lactate is a prognostic factor in patients admitted with suspected ST-elevation myocardial infarction","volume":"51","author":"Frydland","year":"2019","journal-title":"Shock"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/SHK.0000000000001353","article-title":"Serum Lactate and a Relative Change in Lactate as Predictors of Mortality in Patients with Cardiogenic Shock-Results from the Cardshock Study","volume":"53","author":"Lindholm","year":"2020","journal-title":"Shock"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.ijcard.2006.01.024","article-title":"Predictors of in-hospital mortality after percutaneous coronary intervention for cardiogenic shock","volume":"114","author":"Valente","year":"2007","journal-title":"Int. J. Cardiol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0002-9343(01)01070-1","article-title":"Prognosis of patients who develop acute renal failure during the first 24 hours of cardiogenic shock after myocardial infarction","volume":"112","author":"Koreny","year":"2002","journal-title":"Am. J. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1161\/CIRCHEARTFAILURE.112.967224","article-title":"Percutaneous left-ventricular support with the Impella-2.5-assist device in acute cardiogenic shock: results of the Impella-EUROSHOCK-registry","volume":"6","author":"Lauten","year":"2013","journal-title":"Circ. Heart Fail."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/MCC.0b013e328010ba4f","article-title":"Measurement of acid-base resuscitation endpoints: lactate, base deficit, bicarbonate or what?","volume":"12","author":"Englehart","year":"2006","journal-title":"Curr. Opin Crit. Care"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3109\/17482941.2011.655293","article-title":"Lactate clearance in cardiogenic shock following ST elevation myocardial infarction: a pilot study","volume":"14","author":"Lazzeri","year":"2012","journal-title":"Acute Card. Care"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.cardfail.2021.08.012","article-title":"Lactate clearance is associated with improved survival in cardiogenic shock: a systematic review and meta-analysis of prognostic factor studies","volume":"27","author":"Marbach","year":"2021","journal-title":"J. Card Fail."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"e023322","DOI":"10.1161\/JAHA.121.023322","article-title":"Lactate Clearance as a Surrogate for Mortality in Cardiogenic Shock: Insights from the DOREMI Trial","volume":"11","author":"Marbach","year":"2022","journal-title":"J. Am. Heart Assos."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Park, I.H., Cho, H.K., Oh, J.H., Chun, W.J., Park, Y.H., Lee, M., Kim, M.S., Choi, K.H., Kim, J., and Bin Song, Y. (2021). Clinical Significance of Serum Lactate in Acute Myocardial Infarction: A Cardiac Magnetic Resonance Imaging Study. J. Clin. Med., 10.","DOI":"10.3390\/jcm10225278"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"4151","DOI":"10.1177\/0300060519857021","article-title":"Association of hemoglobin with incidence of in-hospital cardiac arrest in patients with acute coronary syndrome complicated by cardiogenic shock","volume":"47","author":"Xu","year":"2019","journal-title":"J. Int. Med. Res."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"J\u00e4ntti, T., Tarvasm\u00e4ki, T., Harjola, V.-P., Parissis, J., Pulkki, K., Javanainen, T., Tolppanen, H., Jurkko, R., Hongisto, M., and Kataja, A. (2019). Hypoalbuminemia is a frequent marker of increased mortality in cardiogenic shock. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0217006"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.jsha.2014.04.004","article-title":"Value of N-terminal pro brain natriuretic peptide in predicting prognosis and severity of coronary artery disease in acute coronary syndrome","volume":"26","author":"Radwan","year":"2014","journal-title":"J. Saudi Heart Assoc."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1097\/CCM.0b013e31819fe896","article-title":"Early assessment of outcome in cardiogenic shock: Relevance of plasma N-terminal pro-B-type natriuretic peptide and interleukin-6 levels","volume":"37","author":"Jarai","year":"2009","journal-title":"Crit. Care Med."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jacc.2004.04.033","article-title":"B-type natriuretic peptide at presentation and prognosis in patients with ST-segment elevation myocardial infarction: an ENTIRE\u2013TIMI-23 substudy","volume":"44","author":"Mega","year":"2004","journal-title":"J. Am. Coll Cardiol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1001\/archinte.165.14.1643","article-title":"Systemic inflammatory response syndrome after acute myocardial infarction complicated by cardiogenic shock","volume":"165","author":"Kohsaka","year":"2005","journal-title":"Arch. Intern. Med."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/CRD.0000000000000190","article-title":"Predictors of Outcomes in Myocardial Infarction and Cardiogenic Shock","volume":"26","author":"Acharya","year":"2018","journal-title":"Cardiol. Rev."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1161\/CIRCULATIONAHA.106.613596","article-title":"Cardiogenic shock: Current concepts and improving outcomes","volume":"117","author":"Reynolds","year":"2008","journal-title":"Circulation"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1097\/00003246-200209000-00007","article-title":"Multiple organ failure in patients with cardiogenic shock is associated with high plasma levels of interleukin-6","volume":"30","author":"Geppert","year":"2002","journal-title":"Crit. Care Med."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1097\/01.CCM.0000228919.33620.D9","article-title":"Plasma concentrations of interleukin-6, organ failure, vasopressor support, and successful coronary revascularization in predicting 30-day mortality of patients with cardiogenic shock complicating acute myocardial infarction","volume":"34","author":"Geppert","year":"2006","journal-title":"Crit. Care Med."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s00392-011-0403-3","article-title":"Interleukin-6, -7, -8 and -10 predict outcome in acute myocardial infarction complicated by cardiogenic shock","volume":"101","author":"Prondzinsky","year":"2012","journal-title":"Clin. Res. Cardiol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1007\/s00063-012-0117-y","article-title":"Acute myocardial infarction and cardiogenic shock: prognostic impact of cytokines: INF-\u03b3, TNF-\u03b1, MIP-1\u03b2, G-CSF, and MCP-1\u03b2","volume":"107","author":"Prondzinsky","year":"2012","journal-title":"Med. Klin. Intensivmed. Notfmed."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1177\/2048872616637036","article-title":"Activated protein C levels and outcome in patients with cardiogenic shock complicating acute myocardial infarction","volume":"6","author":"Fellner","year":"2017","journal-title":"Eur. Heart J. Acute Cardiovasc. Care"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ijcard.2016.11.072","article-title":"Catalytic iron in acute myocardial infarction complicated by cardiogenic shock\u2014A biomarker substudy of the IABP-SHOCK II-trial","volume":"227","author":"Fuernau","year":"2017","journal-title":"Int. J. Cardiol."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Rochette, L., Meloux, A., Rigal, E., Zeller, M., Cottin, Y., and Vergely, C. (2019). The Role of Osteoprotegerin and Its Ligands in Vascular Function. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20030705"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1002\/ejhf.117","article-title":"Growth-differentiation factor 15 and osteoprotegerin in acute myocardial infarction complicated by cardiogenic shock: a biomarker substudy of the IABP-SHOCK II-trial","volume":"16","author":"Fuernau","year":"2014","journal-title":"Eur. J. Heart Fail."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1016\/j.ijcard.2012.05.101","article-title":"Osteoprotegerin in ST-elevation myocardial infarction: prognostic impact and association with markers of myocardial damage by magnetic resonance imaging","volume":"167","author":"Fuernau","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1186\/s13054-014-0713-8","article-title":"Fibroblast growth factor 23 in acute myocardial infarction complicated by cardiogenic shock: a biomarker substudy of the Intraaortic Balloon Pump in Cardiogenic Shock II (IABP-SHOCK II) trial","volume":"18","author":"Fuernau","year":"2014","journal-title":"Crit. Care"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1172\/JCI46122","article-title":"FGF23 induces left ventricular hypertrophy","volume":"121","author":"Faul","year":"2011","journal-title":"J. Clin. Invest."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"e000584","DOI":"10.1161\/JAHA.113.000584","article-title":"Fibroblast growth factor-23 and cardiac structure and function","volume":"3","author":"Agarwal","year":"2014","journal-title":"J. Am. Heart Assoc."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Akwii, R.G., Sajib, M.S., Zahra, F.T., and Mikelis, C.M. (2009). Role of Angiopoietin-2 in Vascular Physiology and Pathophysiology. Cells, 8.","DOI":"10.3390\/cells8050471"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1002\/ejhf.342","article-title":"Angiopoietin-2 in acute myocardial infarction complicated by cardiogenic shock-a biomarker substudy of the IABP-SHOCK II-Trial","volume":"17","author":"Fuernau","year":"2015","journal-title":"Eur. J. Heart Fail."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1093\/eurheartj\/ehs487","article-title":"Circulating angiopoietins and cardiovascular mortality in cardiogenic shock","volume":"34","author":"Link","year":"2013","journal-title":"Eur. Heart J."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1093\/eurheartj\/ehz488","article-title":"Predicting outcomes in cardiogenic shock: are we at risk of having too many scores but too little information?","volume":"40","author":"Yusef","year":"2019","journal-title":"Eur. Heart J."}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/10\/6\/1328\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:24:47Z","timestamp":1760138687000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/10\/6\/1328"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,5]]},"references-count":65,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022,6]]}},"alternative-id":["biomedicines10061328"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines10061328","relation":{},"ISSN":["2227-9059"],"issn-type":[{"type":"electronic","value":"2227-9059"}],"subject":[],"published":{"date-parts":[[2022,6,5]]}}}